Associate Professor, Medicine, University of Alabama School of Medicine
Cardiology
Dr. Salpy V. Pamboukian, MD
|
|
Give Review
Salpy Pamboukian works in the field of Cardiology. She over the years received 3 awards: "Regional Top Doctor", "Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Salpy Pamboukian is also a published physician. She has 52 paper published. The most recent paper is: High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulator... She accepts Medicare payments and is registered with Medicare.gov.
Publications
- Have risk factors for mortality after Heart transplantation changed over time? Insights from 19 years of Cardiac Transplant Research Database study.
- Ambulatory extra-aortic counterpulsation in patients with moderate to severe chronic Heart failure.
- Utility of double-balloon enteroscopy in patients with left ventricular assist devices and obscure overt gastrointestinal bleeding.
- Octreotide in the Mangement of Recurrent Gastrointestinal Bleed in Patients Supported by Continuous Flow Left Ventricular Assist Devices.
- "Cancer in end stage Heart failure patients supported by left ventricular assist devices: Case series."
- Infection and Rejection Risk After Cardiac Transplantation Comparing Induction with Interleukin II Receptor blocker, Antithymocyte Globulin, or No Induction: a multi -...
- Outcomes of Patients with Peripartum Cardiomyopathy Who Received Mechanical Circulatory Support: Data from the INTERMACS Registry.
- Opportunities for improvement in Heart transplantation outcomes for young adults 18 to 35 years of age.
- Total lymphoid irradiation in Heart transplantation: long-term efficacy and survival-an 18-year experience.
- Fulminant myocarditis as a late sequela of DRESS: two cases.
- Use of a vascular plug to percutaneously occlude the outflow conduit of a dysfunctional left ventricular assist device.
- Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol.
- Mechanical circulatory support: we are halfway there.
- Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with Heart failure.
- Minimizing infection and rejection death: clues acquired from 19 years of multi-institutional cardiac transplantation data.
- Use of gated cardiac computed tomography angiography in the assessment of left ventricular assist device dysfunction.
- Balancing rejection and infection with respect to age, race, and gender: clues acquired from 17 years of cardiac transplantation data.
- Device related infections: are we making progress?
- Bradycardia and Syncope as a presentation of cardiac allograft rejection involving the conducting system.
- Safety and efficacy of ibutilide in Heart transplant recipients.
- Invasive monitoring in patients with Heart failure.
- Treprostinil-based therapy in the treatment of moderate-to-severe Pulmonary arterial hypertension: long-term efficacy and combination with bosentan.
- Use of an intraperitoneal ventricular assist device with a polytetrafluoroethylene barrier decreases infections.
- Factors associated with non-adherence to therapy with warfarin in a population of chronic Heart failure patients.
- Acute take-off of the right coronary artery with long intra-aortic wall course presenting as chronic coronary ostium occlusion in a patient with end-stage heart failure.
- Implantable hemodynamic monitoring devices in Heart failure.
- Disparities by insurance status in quality of care for elderly patients with unstable Angina.
- The presence of HLA-directed antibodies after Heart transplantation is associated with poor allograft outcome.
- Managing device infections: are we progressing or is infection an insurmountable obstacle?
- Relationship between bridging with ventricular assist device on rejection after Heart transplantation.
- Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device.
- Influence of race in Heart failure and cardiac transplantation: mortality differences are eliminated by specialized, comprehensive care.
- Neurologic aspects of Heart transplantation.
- Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation.
- Implantation of the HeartWare HVAD in a Child After a Recent Thromboembolic Stroke.
- Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the Seattle Heart failure model.
- The future of implantable hemodynamic monitors.
- Re-stenosis after drug-eluting stents in cardiac allograft vasculopathy.
- Post-Heart transplant diastolic dysfunction is a risk factor for mortality.
- Response of doxorubicin-induced cardiomyopathy to the current management strategy of Heart failure.
- Native Aortic valve insufficiency in patients with left ventricular assist devices.
- Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis.
- Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy.
- Post-operative obesity and cachexia are risk factors for morbidity and mortality after Heart transplant: multi-institutional study of post-operative weight change.
- The use of milrinone in pre-transplant assessment of patients with congestive Heart failure and pulmonary hypertension.
- Carvedilol improves functional class in patients with severe left ventricular dysfunction referred for Heart transplantation.
- Management strategies for heparin-induced thrombocytopenia in Heart-transplant candidates: case report and review of the literature.
- Flow panel reactive antibody monitoring following Heart transplantation.
- Use of Retrospectively Gated CT Angiography to Diagnose Systolic LVAD Inflow Obstruction.
- Infections, Arrhythmias, and Hospitalizations on Home IntraVenous Inotropic Therapy.
- High early event rates in patients with questionable eligibility for advanced Heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulator...
Schools
University Of Toronto Faculty Of Medicine
University Of British Columbia
University Of Toronto
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
- Fellow (FACC)
Hospital
-
University of Alabama Hospital
Drug Facts
| NPI NUMBER | 1689607863 | |
| NPPES Provider LastName | PAMBOUKIAN | |
| NPPES Provider FirstName | SALPY | |
| NPPES Provider ZIPCode | 35233 | |
| NPPES Provider State | AL | |
| Specialty Description | Cardiology | |
| Total Claim Count | 4544.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 44.0 | |
| Percent Opioid Claims | 0.97 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1689607863 |
| Last Name Of The Provider | PAMBOUKIAN |
| First Name Of The Provider | SALPY |
| View All |
Similar Doctors
|
|
Dr. Richard L. Cox Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John T. Eagan Sr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allan S. Wilensky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin T. Bailey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher J. Douglas, MD |
|
|
Dr. Paul J. Troup, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacob C. Townsend, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sumanth D. Prabhu, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Martin Cadeiras, MD
This Doctor is OpenDoctor Recommended.
|